26th Jan 2022 7:00 am |
RNS |
Interim Results for the 6 months ended 31 Oct 2021 |
22nd Dec 2021 9:45 am |
RNS |
Notice of Interim Results |
13th Dec 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
13th Dec 2021 4:36 pm |
RNS |
Price Monitoring Extension |
23rd Nov 2021 3:58 pm |
RNS |
Result of AGM |
19th Nov 2021 7:00 am |
RNS |
First patient dosed in SCIB1 Phase 2 trial |
3rd Nov 2021 10:28 am |
RNS |
Director Dealing |
2nd Nov 2021 10:07 am |
RNS |
Director Dealing |
1st Nov 2021 9:50 am |
RNS |
Notice of Annual General Meeting |
29th Oct 2021 7:00 am |
RNS |
Results for the year ended 30 April 2021 |
28th Oct 2021 11:23 am |
RNS |
Extension of CLN Redemption Dates |
19th Oct 2021 7:00 am |
RNS |
New facilities at The Oxford Science Park |
15th Oct 2021 7:00 am |
RNS |
Notice of Final Results |
5th Oct 2021 4:22 pm |
RNS |
First subject dosed in COVIDITY clinical trial |
9th Sep 2021 4:31 pm |
RNS |
PDMR dealing |
26th Aug 2021 7:00 am |
RNS |
Modi-1 Phase I/II CTA approved by MHRA |
17th Aug 2021 7:00 am |
RNS |
Scancell selects PharmaJet’s Needle-free Systems |
30th Jul 2021 9:52 am |
RNS |
Director Dealing |
29th Jul 2021 7:00 am |
RNS |
COVIDITY Phase 1 trial application in SA approved |
28th Jul 2021 5:00 pm |
RNS |
Lindy Durrant appointed CEO of Scancell |
22nd Jun 2021 7:00 am |
RNS |
COVIDITY trial planned in South Africa and UK |
15th Jun 2021 7:00 am |
RNS |
Appointment of Joint Broker |
8th Jun 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
8th Jun 2021 4:35 pm |
RNS |
Price Monitoring Extension |
7th Jun 2021 8:49 am |
RNS |
Director Dealing |
30th Apr 2021 10:48 am |
RNS |
Director Dealing |
10th Mar 2021 9:58 am |
RNS |
Holding(s) in Company |
2nd Mar 2021 4:40 pm |
RNS |
Second Price Monitoring Extn |
2nd Mar 2021 4:35 pm |
RNS |
Price Monitoring Extension |
19th Feb 2021 3:00 pm |
RNS |
Director Dealing |
19th Feb 2021 7:00 am |
RNS |
Director Dealing |
17th Feb 2021 2:04 pm |
RNS |
Director Dealing |
16th Feb 2021 3:00 pm |
RNS |
BLOCK LISTING SIX MONTHLY RETURN |
15th Feb 2021 3:36 pm |
RNS |
Statement regarding share price movement |
15th Feb 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
15th Feb 2021 11:00 am |
RNS |
Price Monitoring Extension |
15th Feb 2021 9:05 am |
RNS |
Second Price Monitoring Extn |
15th Feb 2021 9:00 am |
RNS |
Price Monitoring Extension |
3rd Feb 2021 7:00 am |
RNS |
Update on SCIB2 clinical development partnership |
29th Jan 2021 7:00 am |
RNS |
Interim Results for the 6 months ended 31 Oct 2020 |